Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $12.25 is 13.95% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 12.84||$ 25.96|
|Low:||$ 12.20||$ 10.75|
Company Description (as filed with the SEC)
On January 4, 2018, Inotek Pharmaceuticals Corporation ("Inotek") and privately held Rocket Pharmaceuticals, Ltd. ("Rocket Ltd") completed a business combination in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), dated as of September 12, 2017, by and among Inotek, Rome Merger Sub, a wholly owned subsidiary of Inotek ("Merger Sub"), and Rocket Ltd, pursuant to which Merger Sub merged with and into Rocket Ltd, with Rocket Ltd surviving as a wholly owned subsidiary of Inotek. This transaction is referred to as the "Reverse Merger." Immediately following the Reverse Merger, Inotek changed its name to "Rocket Pharmaceuticals, Inc." In connection with the closing of the Reverse Merger, our common stock began trading on The Nasdaq Global Market under the ticker symbol "RCKT" on January 5, 2018. The Reverse Merger has been accounted for as a reverse merger under the acquisition method of accounting. ... More ...
Nasdaq Official Price
Jul. 23, 2019
Jul. 23, 2019